Twist Bioscience Corp (TWST): Cash & Equivalents

Annual figures by period end, from SEC filings.

$533.99M
As of 2026-09-30
+23.1%
3-year compound annual growth
+2.8%
5-year compound annual growth
2017-09-30: $31.23M2018-09-30: $80.76M2019-09-30: $46.73M2020-09-30: $93.67M2021-09-30: $465.83M2022-09-30: $378.69M2023-09-30: $286.47M2024-09-30: $226.32M2025-09-30: $183.05M2026-09-30: $533.99M$533.99M
2017-09-30 Cash & Equivalents (USD) 2026-09-30
Period endedCash & EquivalentsChange YoYSource filing
2026-09-30$533.99M+191.7%2026-11-16, Balance as of period end
2025-09-30$183.05M-19.1%2026-11-16, Balance as of period end
2024-09-30$226.32M-21.0%2025-11-17, Balance as of period end
2023-09-30$286.47M-24.4%2024-11-18, Balance as of period end
2022-09-30$378.69M-18.7%2023-11-21, Balance as of period end
2021-09-30$465.83M+397.3%2023-06-05, Balance as of period end
2020-09-30$93.67M+100.4%2021-11-23, Balance as of period end
2019-09-30$46.73M-42.1%2020-11-27, Balance as of period end
2018-09-30$80.76M+158.6%2020-11-27, Balance as of period end
2017-09-30$31.23Mn/a2019-12-13, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Twist Bioscience Corp (TWST)2026-09-30$533.99M+191.7%
Tarsus Pharmaceuticals, Inc. (TARS)2025-12-31$183.64M+93.7%
ADMA Biologics, Inc. (ADMA)2025-12-31$87.63M-15.0%
Immunocore Holdings plc (IMCR)2025-12-31$467.71M+2.6%
Krystal Biotech, Inc. (KRYS)2025-12-31$496.30M+43.9%
Repligen Corp (RGEN)2025-12-31$566.02M-25.3%
Adaptive Biotechnologies Corp (ADPT)2025-12-31$70.50M+47.1%
Vericel Corp (VCEL)2025-12-31$100.09M+34.3%
Iovance Biotherapeutics, Inc. (IOVA)2025-12-31$163.08M+41.0%

Compare TWST, TARS, ADMA, IMCR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗